Kailera Therapeutics, Inc. (NASDAQ:KLRA – Get Free Report) major shareholder Rtw Investments, Lp purchased 500,000 shares of the business’s stock in a transaction on Monday, April 20th. The shares were bought at an average price of $16.00 per share, for a total transaction of $8,000,000.00. Following the acquisition, the insider owned 10,776,820 shares in the company, valued at $172,429,120. This trade represents a 4.87% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Kailera Therapeutics Stock Performance
Shares of KLRA opened at $25.08 on Friday. Kailera Therapeutics, Inc. has a 1 year low of $23.65 and a 1 year high of $28.23.
Featured Articles
Receive News & Ratings for Kailera Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kailera Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
